Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032675 |
---|---|
Receipt number | R000037258 |
Scientific Title | Multicenter clinical trials to determine the efficacy and safety of consolidation and maintenance therapy with ixazomib, lenalidomide, dexamethasone (IRd) therapy in transplant-ineligible multiple myeloma. |
Date of disclosure of the study information | 2018/06/01 |
Last modified on | 2022/05/25 17:05:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/05/22 11:44:13 | ||
2 | Update | 2018/05/22 20:42:30 | Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2020/05/30 15:27:56 | Key exclusion criteria Key exclusion criteria |
|
4 | Update | 2021/05/24 11:53:50 | Date of IRB Last follow-up date |
|
5 | Update | 2022/05/25 17:05:18 | Recruitment status |